Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Suppressing certain hormones might help prevent prostate cancer.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

BPH treatments can cause sexual side effects affecting quality of life.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

A new compound was effective for imaging prostate cancer in rats.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Two siblings have a rare genetic condition causing curly, coarse hair.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.